chr1-21575777-G-A
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The NM_000478.6(ALPL):c.1042G>A(p.Ala348Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A348D) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000478.6 missense
Scores
Clinical Significance
Conservation
Publications
- adult hypophosphatasiaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae), Orphanet
- childhood hypophosphatasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, ClinGen, Orphanet
- hypophosphatasiaInheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, G2P
- infantile hypophosphatasiaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia
- odontohypophosphatasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- perinatal lethal hypophosphatasiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALPL | NM_000478.6 | c.1042G>A | p.Ala348Thr | missense_variant | Exon 10 of 12 | ENST00000374840.8 | NP_000469.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALPL | ENST00000374840.8 | c.1042G>A | p.Ala348Thr | missense_variant | Exon 10 of 12 | 1 | NM_000478.6 | ENSP00000363973.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypophosphatasia Pathogenic:3
This missense variant is not present in GnomAD 4.1 and affects a highly conserved amino acid in proximity of the active site domain. The variant is predicted to affect protein function (REVEL score: 0.852). Splice-prediction algorithms predict no effect on splicing. In vitro functional studies showed reduced ALP activity without dominant negative effect. This variant has been reported in the literature in individuals affected with ALPL-related conditions (PMID:32160374;PMID:38591765;PMID:38591765;PMID:10679946). The results of the functional testing and the applied ACMG criteria can be viewed at: https://alplmutationdatabase.jku.at/table/
ALPL c.1042G>A is a missense variant that changes the amino acid at residue 348 from Alanine to Threonine. This variant has been observed in at least one proband affected with hypophosphatasia (PMID:11855933;10679946). Functional studies have been reported;however, the significance of the findings remain unclear (PMID:10679946). This variant has been described as Ala331Thr in the literature. It is absent or not present at a significant frequency in gnomAD. In silico models agree that this variant is possibly or probably damaging. In conclusion, we classify ALPL p.Ala348Thr (c.1042G>A) as a likely pathogenic variant.
Variant summary: ALPL c.1042G>A (p.Ala348Thr) results in a non-conservative amino acid change in the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant was absent in 251440 control chromosomes. c.1042G>A has been reported in the literature in compound heterozygous individuals affected with autosomal recessive Hypophosphatasia (Taillandier_2000, Mumm_2002, Del Angel_2020). These data indicate that the variant may be associated with disease. The variant was found impacting protein function by reducing enzymatic activity to between 25-33% compared to wild-type (Taillandier_2000, ALPL Database). The following publications have been ascertained in the context of this evaluation (PMID: 32160374, 11855933, 10679946, 37898381, 25023282, 37422472, 38591765, 11395499, 35320273, 32973344, 18328985, 10737975). ClinVar contains an entry for this variant (Variation ID: 555880). Based on the evidence outlined above, the variant was classified as likely pathogenic for autosomal dominant and autosomal recessive hypophosphatasia.
Childhood hypophosphatasia;C0268412:Infantile hypophosphatasia;C0268413:Adult hypophosphatasia Pathogenic:1
Adult hypophosphatasia Pathogenic:1
not provided Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 348 of the ALPL protein (p.Ala348Thr). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with autosomal recessive hypophosphatasia (PMID: 10679946, 11855933, 32160374). This variant is also known as A331T. ClinVar contains an entry for this variant (Variation ID: 555880). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALPL protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ALPL function (PMID: 10679946). For these reasons, this variant has been classified as Pathogenic.
ALPL-related disorder Uncertain:1
The ALPL c.1042G>A variant is predicted to result in the amino acid substitution p.Ala348Thr. This variant in the compound heterozygous condition along with a second variant in this gene was reported in several individuals with hypophosphatasia (reported as Ala331Thr, Taillandier et al. 2000. PubMed ID: 10679946, Mumm. 2002. PubMed ID: 11855933, Table S2, Del Angel. 2020. PubMed ID: 32160374). In vitro functional studies demonstrate that this variant led to reduced enzyme activity compared to wildtype (Taillandier et al. 2000. PubMed ID: 10679946). This variant has not been reported in a large population database, indicating this variant is rare. Tis variant is interpreted as likely pathogenic.
Infantile hypophosphatasia Uncertain:1
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at